New insights into the burden and costs of multiple sclerosis in Europe

The current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently, healthcare costs have shifted from inpatient care and rehabilitation to outpatient care.

This European burden of illness study provides data that can be combined with other evidence to assess whether management approaches provide value to society.